论文信息 - Sirolimus as a new drug to treat RIF patients with elevated Th17/Treg ratio: A double-blind, phase II randomized clinical trial. - 字舞流文

Sirolimus as a new drug to treat RIF patients with elevated Th17/Treg ratio: A double-blind, phase II randomized clinical trial.

M. Nouri | M. Yousefi | S. Dolati | M. Ahmadi | Z. Babaloo | Z. Nouri | Homayoon Siahmansouri | Shahla Danaii | Mahnaz Ghaebi | Samaneh Abdolmohamadi-Vahid | Sanaz Abbaspour-Aghdam | K. Berjis | Rahime Madadi-Javid